Puta count and particle size are the two critical quality parameters for bulk Bhasma orders.
Bulk buyers of Bhasma and Pishti need to understand puta count and particle size before placing orders, because these two parameters directly determine whether the preparation meets its pharmacopoeial specification. A Bhasma produced with fewer puta cycles than the pharmacopoeial standard requires, or one with coarser particle size than the identity tests demand, fails compliance regardless of how it is labelled.
Bhasma production is fundamentally different from herbal powder manufacturing. In herbal churna production, the primary variables are herb identity, moisture content, and particle size. In Bhasma production, the central process is the transformation of a mineral through repeated high-temperature incineration. Each puta (firing cycle) drives the mineral further towards the pharmacopoeial identity required by the Ayurvedic Pharmacopoeia of India.
A Bhasma that has not completed the required number of puta cycles may fail standard identity tests such as varitara (the ability to float on still water) or rekhapurnata (the ability to fill palm lines without clumping). It may also contain higher residues of the original mineral in forms that are not consistent with the pharmacopoeial description. For a bulk buyer, receiving a sub-standard Bhasma means receiving a product that cannot be incorporated into a compliant classical formulation without creating a pharmacopoeial non-conformance.
Particle size is equally critical. The extreme fineness of a correctly prepared Bhasma is both a physical characteristic required by the pharmacopoeial identity tests and a functional requirement for incorporation into vati (tablets) and other dosage forms at classical ratios.
Puta refers to a single complete incineration cycle in Bhasma preparation. Each puta begins with the preparation of a sharava samputa: the partially processed mineral, combined with a specified herbal paste, is formed into small discs, packed between two shallow earthen dishes (sharava), and sealed with clay. This sealed unit is then embedded in a bed of fuel (traditionally standardised quantities of cowdung cakes) and fired. After the fuel burns down and the crucible cools, the material is inspected and the next puta, if required, is prepared.
The Ayurvedic Pharmacopoeia of India specifies the number of puta for each Bhasma preparation. Some preparations require a single puta; others such as Swarna Bhasma require many more. The fuel quantity per puta is also specified, providing a standardised heat input for each cycle.
When placing a bulk order, a buyer should request the manufacturer's standard operating procedure (SOP) for the specific Bhasma being purchased. The SOP should state the puta count, the fuel quantity, the herbal paste used, and the interval between puta cycles. The batch record for the specific batch being supplied should confirm that the SOP was followed for that batch, and the certificate of analysis should confirm that the resulting material passed identity tests consistent with a complete, correctly processed Bhasma.
A manufacturer offering GMP-certified Ayurvedic contract manufacturing and bulk supply of Bhasma preparations should be able to provide all of this documentation without treating it as an unusual request. Documentation of this depth is standard practice for a Schedule T GMP-compliant manufacturer, and its absence should prompt further enquiry before an order is placed.
Particle size in Bhasma is traditionally assessed through the physical identity tests specified in the Ayurvedic Pharmacopoeia of India. Varitara tests whether the powder can float on still water without sinking, indicating that particle size and density are within the pharmacopoeial range. Rekhapurnata tests whether the powder fills the lines of the palm without clumping or sticking, indicating appropriate fineness.
Modern quality control adds analytical particle size measurement to these classical tests. Scanning electron microscopy (SEM) and particle size analysers can confirm that the majority of particles are within the nanometre to micrometre range expected of a correctly processed Bhasma. Some manufacturers of Bhasma-Pishti preparations include laser diffraction particle size data in their certificates of analysis, which provides an objective, quantified confirmation of particle fineness.
For Pishti preparations, particle size is relevant though the range differs from Bhasma because Pishti is processed by wet trituration rather than incineration. The CoA for Pishti should confirm particle fineness consistent with the pharmacopoeial specification for the specific preparation, along with moisture content, identity of the source mineral, and heavy metal profile.
A bulk buyer's quality documentation checklist for Bhasma and Pishti should include the following, and should be agreed with the supplier before the first order is placed.
A batch-specific certificate of analysis (CoA) confirming all pharmacopoeial parameters: physical identity tests (rekhapurnata, varitara, nishchandratwam), loss on drying, ash value, heavy metal profile (lead, mercury, arsenic, cadmium within API limits), microbial limits, and, for modern batches, quantitative particle size data. The CoA must reference the batch number and the pharmacopoeial standard applied.
A batch manufacturing record summary confirming the puta count completed, the raw material batch used (with its own CoA), the shodhana process applied, and the dates of each processing stage. This provides traceability from raw material to finished Bhasma.
A copy of the manufacturer's current GMP certificate and AYUSH manufacturing licence confirming that the Bhasma-Pishti category is in scope. These documents confirm that the facility producing the material is authorised and audited for this product category.
Before placing a large bulk order for Bhasma or Pishti, a buyer's quality team should review the manufacturer's SOP for the specific preparation and, where possible, visit the manufacturing facility or commission a third-party audit. Key questions to resolve include: Is the puta count specified in the SOP consistent with the pharmacopoeial monograph? Is the fuel quantity per puta standardised and recorded in the batch record? Is identity testing performed after each puta or only at the end of the full process? Is the shodhana stage fully documented?
A manufacturer who cannot answer these questions clearly, or who is unwilling to share the relevant sections of the SOP, is not operating to the documentation standard that a serious bulk buyer should require for classical Rasashastra preparations.
Raasa Ayurveda in Kanpur manufactures 35 classical Bhasma and Pishti formulations within the Bhasma-Pishti category, with seventeen years of classical Ayurveda manufacturing experience. Samples with a full certificate of analysis are offered before bulk orders are placed. To discuss puta count documentation, particle size data, and bulk supply arrangements, contact raasaayurveda@gmail.com or call +91 9415128217.
The Ayurvedic Pharmacopoeia of India specifies the puta count for each Bhasma preparation individually. Lauha Bhasma monographs vary by the specific preparation (for example, Shataputi or Sahasraputi Lauha Bhasma require very different cycle counts). Always confirm the applicable monograph with the manufacturer and verify the puta count in the batch SOP before placing a bulk order.
Failure of the classical identity tests indicates that the Bhasma has not been fully converted through the required number of puta cycles, or that the particle size is not within the pharmacopoeial range. Such material does not meet the pharmacopoeial specification and should not be incorporated into a classical formulation. A GMP-certified manufacturer should reject and reprocess or discard non-conforming batches.
This depends on the manufacturer. GMP-compliant manufacturers increasingly include quantitative particle size data from laser diffraction or SEM analysis in addition to the classical physical identity tests. Buyers should specify that both classical identity tests and quantitative particle size data are required in the CoA before placing an order, to ensure the documentation matches their quality requirements.
A buyer can specify that the Bhasma must be produced to the pharmacopoeial puta count specified in the Ayurvedic Pharmacopoeia of India for that preparation. The manufacturer's SOP should already reflect this. If a buyer has a specific additional requirement beyond the pharmacopoeial standard, this should be discussed and agreed in the product specification before production begins.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.